MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

509099

Report Date :

15.05.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

AMERICAN DIAGNOSTIC CORPORATION

 

 

Registered Office :

55 Commerce Drive Hauppauge, New York, 11788-3931, Usa

 

 

Country :

United States

 

 

Financials (as on) :

2016 (Summarized)

 

 

Date of Incorporation :

16.11.1983

 

 

Legal Form :

Corporation

 

 

Line of Business :

Subject is engaged in manufacturing of medical, surgical, ophthalmic, and veterinary instruments and apparatus.

 

 

No. of Employees :

110

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

United States

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 


 

UNITED STATES - ECONOMIC OVERVIEW

 

The US has the most technologically powerful economy in the world, with a per capita GDP of $59,500. US firms are at or near the forefront in technological advances, especially in computers, pharmaceuticals, and medical, aerospace, and military equipment; however, their advantage has narrowed since the end of World War II. Based on a comparison of GDP measured at purchasing power parity conversion rates, the US economy in 2014, having stood as the largest in the world for more than a century, slipped into second place behind China, which has more than tripled the US growth rate for each year of the past four decades.

 

In the US, private individuals and business firms make most of the decisions, and the federal and state governments buy needed goods and services predominantly in the private marketplace. US business firms enjoy greater flexibility than their counterparts in Western Europe and Japan in decisions to expand capital plant, to lay off surplus workers, and to develop new products. At the same time, businesses face higher barriers to enter their rivals' home markets than foreign firms face entering US markets.

 

Long-term problems for the US include stagnation of wages for lower-income families, inadequate investment in deteriorating infrastructure, rapidly rising medical and pension costs of an aging population, energy shortages, and sizable current account and budget deficits.

 

The onrush of technology has been a driving factor in the gradual development of a "two-tier" labor market in which those at the bottom lack the education and the professional/technical skills of those at the top and, more and more, fail to get comparable pay raises, health insurance coverage, and other benefits. But the globalization of trade, and especially the rise of low-wage producers such as China, has put additional downward pressure on wages and upward pressure on the return to capital. Since 1975, practically all the gains in household income have gone to the top 20% of households. Since 1996, dividends and capital gains have grown faster than wages or any other category of after-tax income.

 

Imported oil accounts for more than 50% of US consumption and oil has a major impact on the overall health of the economy. Crude oil prices doubled between 2001 and 2006, the year home prices peaked; higher gasoline prices ate into consumers' budgets and many individuals fell behind in their mortgage payments. Oil prices climbed another 50% between 2006 and 2008, and bank foreclosures more than doubled in the same period. Besides dampening the housing market, soaring oil prices caused a drop in the value of the dollar and a deterioration in the US merchandise trade deficit, which peaked at $840 billion in 2008. Because the US economy is energy-intensive, falling oil prices since 2013 have alleviated many of the problems the earlier increases had created.

 

The sub-prime mortgage crisis, falling home prices, investment bank failures, tight credit, and the global economic downturn pushed the US into a recession by mid-2008. GDP contracted until the third quarter of 2009, the deepest and longest downturn since the Great Depression. To help stabilize financial markets, the US Congress established a $700 billion Troubled Asset Relief Program (TARP) in October 2008. The government used some of these funds to purchase equity in US banks and industrial corporations, much of which had been returned to the government by early 2011. In January 2009, Congress passed and former President Barack OBAMA signed a bill providing an additional $787 billion fiscal stimulus to be used over 10 years - two-thirds on additional spending and one-third on tax cuts - to create jobs and to help the economy recover. In 2010 and 2011, the federal budget deficit reached nearly 9% of GDP. In 2012, the Federal Government reduced the growth of spending and the deficit shrank to 7.6% of GDP. US revenues from taxes and other sources are lower, as a percentage of GDP, than those of most other countries.

Wars in Iraq and Afghanistan required major shifts in national resources from civilian to military purposes and contributed to the growth of the budget deficit and public debt. Through FY 2018, the direct costs of the wars will have totaled more than $1.9 trillion, according to US Government figures.

 

In March 2010, former President OBAMA signed into law the Patient Protection and Affordable Care Act (ACA), a health insurance reform that was designed to extend coverage to an additional 32 million Americans by 2016, through private health insurance for the general population and Medicaid for the impoverished. Total spending on healthcare - public plus private - rose from 9.0% of GDP in 1980 to 17.9% in 2010.

 

In July 2010, the former president signed the DODD-FRANK Wall Street Reform and Consumer Protection Act, a law designed to promote financial stability by protecting consumers from financial abuses, ending taxpayer bailouts of financial firms, dealing with troubled banks that are "too big to fail," and improving accountability and transparency in the financial system - in particular, by requiring certain financial derivatives to be traded in markets that are subject to government regulation and oversight.

 

In December 2012, the Federal Reserve Board (Fed) announced plans to purchase $85 billion per month of mortgage-backed and Treasury securities in an effort to hold down long-term interest rates, and to keep short-term rates near zero until unemployment dropped below 6.5% or inflation rose above 2.5%. The Fed ended its purchases during the summer of 2014, after the unemployment rate dropped to 6.2%, inflation stood at 1.7%, and public debt fell below 74% of GDP. In December 2015, the Fed raised its target for the benchmark federal funds rate by 0.25%, the first increase since the recession began. With continued low growth, the Fed opted to raise rates several times since then, and in December 2017, the target rate stood at 1.5%.

 

In December 2017, Congress passed and President Donald TRUMP signed the Tax Cuts and Jobs Act, which, among its various provisions, reduces the corporate tax rate from 35% to 21%; lowers the individual tax rate for those with the highest incomes from 39.6% to 37%, and by lesser percentages for those at lower income levels; changes many deductions and credits used to calculate taxable income; and eliminates in 2019 the penalty imposed on taxpayers who do not obtain the minimum amount of health insurance required under the ACA. The new taxes took effect on 1 January 2018; the tax cut for corporations are permanent, but those for individuals are scheduled to expire after 2025. The Joint Committee on Taxation (JCT) under the Congressional Budget Office estimates that the new law will reduce tax revenues and increase the federal deficit by about $1.45 trillion over the 2018-2027 period. This amount would decline if economic growth were to exceed the JCT’s estimate.

 

Source : CIA

 

 

 

STATUTORY INFORMATION

 

Legal Name:

AMERICAN DIAGNOSTIC CORPORATION

Trade Names:

AMERICAN DIAGNOSTIC CORPORATION

ID:

881231

Date Created:

1983

Date Incorporated:

NOVEMBER 16, 1983

Legal Address:

55 COMMERCE DRIVE

HAUPPAUGE, NEW YORK, 11788-3931, USA

Operative Address:

55 COMMERCE DRIVE

HAUPPAUGE, NEW YORK, 11788-3931, USA

Telephone:

1-631-273-9600

Fax:

1-631-273-9659

Legal Form:

CORPORATION

Email:

info@adctoday.com

Registered in:

NEW YORK

Website:

www.adctoday.com

Contact:

MARC BLITSTEIN – Chief Executive Officer

Staff:

110

Activity:

SIC Code 3841, Surgical and Medical Instruments and Apparatus

NAICS Code 339112, Surgical and Medical Instrument Manufacturing

 

 

Banks:

BANK OF AMERICA

 

History:

American Diagnostic Corporation was founded in 1983 by Marc Blitstein and Neal Weingart.

 

 

 

PRINCIPAL ACTIVITY

 

 

The company's line of business includes the manufacturing of medical, surgical, ophthalmic, and veterinary instruments and apparatus.

Products/Services description:

The company offers stethoscopes, Blood Pressure Measurement Devices, Thermometry, Vital Signs Monitors, Pulse Oximeters, Penlights, Caseware, Laryngoscopes, Instruments and Accessories.

Brands:

ADC®, Medicut™, Adscope®, Proscope™, Diagnostix™, Prosphyg™, Adtemp™, Multikuf™, Adlite™, Pocket Pal™, Responder™, Adcuff™, System 5™, Adflow™, Adview®, E-Sphyg™, and Adimals®

Sales are:

Wholesale

Clients:

Nova Medica Ltda

Katty Guzman Q/Biomedical INT

Enraf Medica Eirl

Mannah Srl.

Bustamante Reyes Mary Esther.

Suppliers:

Rudolf Riester Gmbh

Microlife American Trading Corp

Yuyao Densway Medical Instruments

Invotech Excel FZCO.

Pt. Sugih Instrumendo Abadi

Operations area:

National and International

The company imports from

GERMANY

TAIWAN

CHINA

UNITED ARAB EMIRATES

INDONESIA

The company exports to

COLOMBIA

BOLIVIA

PERU

PARAGUAY

ECUADOR

The subject employs

110 employees

Payments:

Regular

 

 

 

LOCATION

 

Headquarters :

55 COMMERCE DRIVE

HAUPPAUGE, NEW YORK, 11788-3931, USA

Comments on Address:

-

Branches:

No other branches were found.

Related Companies:

ADC (UK) Limited

Unit 6, Fareham Enterprise Centre

Newgate Lane

Fareham

Hants, UK P014 1TH

 

 

 

GROUP STRUCTURE AND SUBSIDIARY COMPANIES

 

Listed at the stock exchange:

NO

Capital:

NA

Shareholders:

The major holders of this company are:
Marc Blitstein

Neal Weingart

Management:

MARC BLITSTEIN – Chief Executive Officer

 

 

 

FINANCIAL INFORMATION

 

 

The company does not make its financial statements public. The following information has been provided by private sources:

 

 

USD 2016

 

Estimated Net Assets

3.360.000

Cash flow

Normal

 

 

LEGAL FILINGS

 

 

 

CASES

No found.

 

 

TRADEMARKS

AMERICAN DIAGNOSTIC CORPORATION

MEDICAL INSTRUMENTS, PARTS AND ACCESSORIES, NAMELY, STETHOSCOPES, STETHOSCOPE REPLACEMENT PARTS, BLOOD PRESSURE UNITS SPHYGMOMANOMETERS…

Owned by: AMERICAN DIAGNOSTIC CORPORATION

Serial Number: 75398197

 

ADC

MEDICAL INSTRUMENTS, PARTS AND ACCESSORIES, NAMELY, STETHOSCOPES, STETHOSCOPE REPLACEMENT PARTS, BLOOD PRESSURE UNITS SPHYGMOMANOMETERS…

Owned by: AMERICAN DIAGNOSTIC CORPORATION

Serial Number: 75437715

 

MEDICUT

Medical shears for use by Emergency Medical Technicians ("EMTs")

Owned by: AMERICAN DIAGNOSTIC CORPORATION

Serial Number: 86722691

 

ADC

MEDICAL INSTRUMENTS, PARTS AND ACCESSORIES, NAMELY, PULSE OXIMETERS, NON-INVASIVE BLOOD PRESSURE MONITORS, STETHOSCOPES,…

Owned by: AMERICAN DIAGNOSTIC CORPORATION

Serial Number: 87591279

 

 

RENEWAL HISTORY

Filing Date        Name Type       Entity Name

AUG 08, 1990    Actual   AMERICAN DIAGNOSTIC CORPORATION

NOV 16, 1983    Actual   AMERICAN DIAGNOSTIC CORP.

 

 

UCC

Debtor Names:  AMERICAN DIAGNOSTIC CORPORATION         

55 COMMERCE DRIVE, HAUPPAUGE, NY 11788-3931, USA

Secured Party Names:   CROWN CREDIT COMPANY     

44 S WASHINGTON STREET, NEW BREMEN, OH 45869-0000, USA

File no. File Date           Lapse Date       Filing Type       

154976  07/02/2002        07/02/2007        Financing Statement     

 

Debtor Names:  AMERICAN DIAGNOSTIC CORPORATION

55 COMMERCE DRIVE, HAUPPAUGE, NY 11788, USA

Secured Party Names:   CITIBANK, N.A.

ONE COURT SQUARE 43RD FLOOR, LONG ISLAND CITY, NY 11120, USA

File no. File Date           Lapse Date       Filing Type       

200402125116530          02/12/2004        02/12/2009        Financing Statement        

200812126323919          12/12/2008        02/12/2014            Continuation

201310216110750          10/21/2013        02/12/2019            Continuation

 

Debtor Names:  AMERICAN DIAGNOSTIC CORPORATION         

55 COMMERCE DRIVE, HAUPPAUGE, NY 11788, USA

Secured Party Names:   CROWN CREDIT COMPANY     

40 S. WASHINGTON STREET, NEW BREMEN, OH 45869, USA

File no. File Date           Lapse Date       Filing Type       

200706255616454          06/25/2007        06/25/2012        Financing Statement        

 

Debtor Names:  AMERICAN DIAGNOSTIC CORPORATION         

55 COMMERCE DRIVE, HAUPPAUGE, NY 11788, USA

Secured Party Names:   CROWN CREDIT COMPANY     

40 S. WASHINGTON STREET, NEW BREMEN, OH 45869, USA

File no. File Date           Lapse Date       Filing Type       

200806195691463          06/19/2008        06/19/2013        Financing Statement        

 

Debtor Names:  AMERICAN DIAGNOSTIC CORPORATION         

55 COMMERCE DRIVE , HAUPPAUGE, NY 11788, USA

AMERICAN DIAGNOSTIC CORPORATION         

55 COMMERCE DRIVE, HAUPPAUGE, NY 11788, USA

Secured Party Names:   JPMORGAN CHASE BANK, N.A.          

P. O. BOX 2558 1111 FANNIN TX2-F135, HOUSTON, TX 77252-2558, USA

File no. File Date           Lapse Date       Filing Type       

200901235077690          01/23/2009        01/23/2014        Financing Statement        

201205105549891          05/10/2012        01/23/2014        Financing Statement Amendment 

201308295923981          08/29/2013        01/23/2019            Continuation

201508105885592          08/10/2015        01/23/2019        Termination

 

 

OFAC Sanctions List Search

The company is not listed in the OFAC list.

 

 

 

 

SUMMARY

 

 

Founded in 1983, American Diagnostic Corporation is an organization in the Surgical and Medical Instrument Manufacturing Industry headquartered in Hauppaugue, NY.

 

The company has 110 regular employees and generates an estimated $3.6 million USD in annual estimated net assets.

 

It operates nationally and internationally, mainly exporting to Colombia, Bolivia, Peru, Paraguay and Ecuador.

 

It is ACTIVE in business with no negative records.

 

 

RISK INFORMATION

 

 

 

DEBTS

Controlled

PAYMENTS

Regular

CASH FLOW

Normal

STATUS

Active

 

 

INTERVIEW

 

NAME

Tina

POSITION

Sales

COMMENTS

She confirmed the name of the company, the address of the headquarters and location, the date of creation of the company, the number of employees and the name of the Chief Executive Officer.


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

INR 67.31

UK Pound

1

INR 91.24

Euro

1

INR 80.50

US Dollar

1

INR 80.57

 

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

DNS

 


 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.